A Quick Synthesis of 1-Arylpyrrolopyrazinones from Linear Alkynylamide Derivatives

Abstract

A rapid synthesis of pyrrolopyrazinone derivatives based on formal double addition across the triple bond of appropriately substituted substrates is presented. The key cyclization step features the formation, mediated by [bis(trifluoroacetoxy)iodo]benzene ­(PIFA), of a 5-aroylpyrrolidinone nucleus from appropriately func­t­ionalized N-protected N-(aminoethyl)amides. After removal of the protecting group, the free amino group is used to accomplish a second heterocyclization process onto the newly formed carbonyl group. By appropriate manipulation of these protecting groups and selection of reaction conditions, a series of pyrrolopyrazinones can be obtained in different stages of hydrogenation.

hypervalent iodine - alkynylamides - reductive aminations - pyrazinones - bicyclic compounds

References

1 For a review on pharmacological properties and clinical uses of piracetam, see: Winblad B. CNS Drug Rev.  2005,  11:  169 

2 Pramiracetam (C) has shown improved efficacy in patients with senile or presenile cognitive impairment. See: Manetti D. Ghelardini C. Bartolini A. Bellucci C. Dei S. Galeotti N. Gualtieri F. Romanelli MN. Scapecchi S. Teodori E. J. Med. Chem.  2000,  43:  1969 

Nefiracetam (D) has been shown to modulate receptor systems such as the cholinergic and/or glutamatergic ones. See:

3a Moriguchi S. Shioda N. Maejima H. Zhao X. Marszalec W. Yeh JZ. Fukunaga K. Narahashi T. Mol. Pharmacol.  2007,  71:  580 

3b Zhao X. Kuryatov A. Lindstrom JM. Yeh JZ. Narahashi T. Mol. Pharmacol.  2001,  59:  674 

4a Martini E. Ghelardini C. Bertucci C. Dei S. Gualtieri F. Guandalini L. Manetti D. Scapecchi S. Teodori E. Romanelli MN. Med. Chem.  2005,  1:  473 

4b

See also ref. 2.

5a Farina C. Gagliardi S. Ghelardini C. Martinelli M. Norcini M. Parini C. Petrillo P. Ronzoni S. Bioorg. Med. Chem.  2008,  16:  3224 

5b Pinza M. Farina C. Cerri A. Pfeiffer U. Riccaboni MT. Banfi S. Biagetti R. Pozzi O. Magnani M. Dorigotti L. J. Med. Chem.  1993,  36:  4214 

6a Tellitu I. Serna S. Herrero MT. Moreno I. Domínguez E. SanMartin R. J. Org. Chem.  2007,  72:  1526 

6b Serna S. Tellitu I. Domínguez E. Moreno I. SanMartin R. Org. Lett.  2005,  7:  3073 

The pyrrolopyrazinone (1,4-diazabicyclo[4.3.0]nonane) skeleton has also been identified as the bicyclic constituent of the recently isolated natural product tunicyclin A. See:

7a Tian J.-M. Shen Y.-H. Yang X.-W. Liang S. Tang J. Shan L. Zhang W.-D. Org. Lett.  2009,  11:  1131 

7b See also: Macías A. Alonso E. Del Pozo C. González J. Tetrahedron Lett.  2004,  45:  4657 

8

In previous unpublished results from our group, we found that the presence of free amino and also hydroxy groups is not compatible with the PIFA-assisted intramolecular heterocyclization of unsaturated amides.

For the synthetic and spectroscopic details of monoprotected diamines 1a,b, see, respectively:

9a Guy J. Caron K. Dufresne S. Michnick SW. Skene WG. Keillor JW. J. Am. Chem. Soc.  2007,  129:  11969 

9b Krivickas SJ. Tamanini E. Todd MH. Watkinson M. J. Org. Chem.  2007,  72:  8280 

For some recent reviews on the Sonogashira reaction, see:

10a Heravi MM. Sadjadi S. Tetrahedron  2009,  65:  7761 

10b Chinchilla R. Nájera C. Chem. Rev.  2007,  107:  874 

10c Doucet H. Hierso JC. Angew. Chem. Int. Ed.  2007,  46:  834 

11 These results led us to propose a mechanism in which the activated triple bond easily coordinates with the iodine(III) reagent and, hence, assisting the nucleophilic attack of the amidic nitrogen. In addition, alkyl-substituted alkynes also failed in the PIFA-mediated cyclization step

For recent books or reviews concerning the chemistry of the hypervalent iodine reagents, see:

12a Varvoglis A. The Organic Chemistry of Polycoordinated Iodine   Wiley-VCH; New York: 1992. 

12b Varvoglis A. Hypervalent Iodine in Organic Synthesis   Academic Press; London: 1997. 

12c Hypervalent Iodine Chemistry   Wirth T. Springer; Berlin: 2003. 

12d Togo H. Katoghi M. Synlett  2001,  566 

12e Togo H. Sakurani M. Synlett  2002,  1966 

12f Zhdankin VV. Stang PJ. Chem. Rev.  2002,  102:  2523 

12g Dauban P. Dodd RH. Synlett  2003,  11 

12h Stang PJ. J. Org. Chem.  2003,  68:  2997 

12i Wirth T. Angew. Chem. Int. Ed.  2005,  44:  3656 

12j Richardson RD. Wirth T. Angew. Chem. Int. Ed.  2006,  45:  4402 

12k Ciufolini MA. Braun NA. Canesi S. Ousmer M. Chang J. Chai D. Synthesis  2007,  3759 

12l Quideau S. Pouységu L. Deffieux D. Synlett  2008,  467 

12m Zhdankin VV. Stang PJ. Chem. Rev.  2008,  108:  5299 

12n Zhdankin VV. ARKIVOC  2009,  (i):  1 

For previous alternative approaches to the synthesis of this skeleton, see:

13a Scapecchi S. Martini E. Manetti D. Ghelardini C. Martelli C. Dei S. Galeotti N. Guandalini L. Romanelli MN. Teodori E. Bioorg. Med. Chem.  2004,  12:  71 

13b Godet T. Bonvin Y. Vicent G. Merle D. Thozet A. Ciufolini MA. Org. Lett.  2004,  6:  3281 

13c Hulme C. Ma L. Cherrier MP. Romano JJ. Morton G. Duquenne C. Salvino J. Labaudiniere R. Tetrahedron Lett.  2000,  41:  1883 

13d Martín-Martínez M. Ballaz S. Latorre M. Herranz R. García-López MT. Cenarruzabeitia E. Del Río J. González-Muñiz R. Chem. Pharm. Bull.  1998,  46:  782 

13e Roth E. Altman J. Kapon M. Ben-Ishai D. Tetrahedron  1995,  51:  801 

13f

See also ref. 2.

14

Additional attempts to hydrogenate unsaturated pyrrolo-pyrazinone 13a to afford 14a resulted in the recovery of the unchanged starting material. Hydrogenation of the imine intermediate J appears to proceed much faster than the isomerization process that would lead to its enamine tautomer.

15

Diastereomers 14 showed a significant NOE between the H1 and H8a protons, indicating that they are located on the same face of the heterocyclic ring.

16

It is known that, in some cases, thiophene-containing olefins can be unreactive under palladium-catalyzed hydrogenation conditions.